Drug Topics
AUGUST 16, 2023
National organizations call for Improvements to youth mental health care, Wednesday marks 1 year since passing of Inflation Reduction Act, and a new study finds link between fracking and lymphoma.
Pharmacy Times
AUGUST 16, 2023
The daily oral formulation of ketamine, KET01, has the potential to greatly improve the standard treatment practices for treatment-resistant depression, according to investigators.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 16, 2023
As AI becomes more prevalent, how must the pharmacy world change how it learns?
Pharmacy Times
AUGUST 16, 2023
Key study finding shows associations between the beat frequency in the rhythmic stimulus in the frontal left sites of infant brains and pathways related to brain modulation and nucleotide levels.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Healthcare
AUGUST 16, 2023
Cigna has launched a new tool that will allow its members to use their smartphones to check for dental health issues including gum disease and cavities. | Cigna has launched a new tool that will allow its members to use their smartphones to check for dental health issues including gum disease and cavities.
Pharmacy Times
AUGUST 16, 2023
Pharmacies brace for a double wave of DIR fees while paddling against profit struggles. Enter Pharmacy AI: a transformative vehicle to navigate stormy waters, enhance efficiency, and prioritize patient care.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 16, 2023
Experts discuss the social determinants that can affect the rates of flu immunizations and strategies to boost immunization rates.
STAT
AUGUST 16, 2023
Sarah Evans considers herself a lucky ovarian cancer patient, though she is dealing with the second recurrence of the disease since she was first diagnosed in February 2018. She is grateful that, even by her third round of chemo in March of this year, her cancer was still responding to carboplatin treatment — the most common first line of treatment for ovarian cancer, and one Evans tolerates without unbearable side effects.
Pharmacy Times
AUGUST 16, 2023
Chad Worz, PharmD, BCGP, FASCP, and the panel review the NUDGE-FLU Trial and discuss the study design, outcomes, and how similar nudges can be incorporated into practice.
STAT
AUGUST 16, 2023
The nation’s health faces a dual threat — one anticipated, the other, self-inflicted. Covid-19 has not gone away; the Centers for Disease Control and Prevention reports that infections are showing signs of a late summer wave. The new strain, EG.5 , spreads easily and is more resistant to neutralizing antibodies but does not, to date, seem to be more virulent.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
AUGUST 16, 2023
Melphalan/hepatic delivery system (Hepzato Kit; Delcath Systems Inc) is currently the only liver-directed therapy approved by the FDA for the treatment of netastatic uveal melanoma and percutaneous hepatic perfusion.
STAT
AUGUST 16, 2023
In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time. The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.
Pharmacy Times
AUGUST 16, 2023
Intravenous immunoglobulin was found to be the most effective immunotherapy in preventing relapses after treatment with steroids in pediatric patients.
Pharmaceutical Technology
AUGUST 16, 2023
The proportion of cases found in migrants to Florida has decreased significantly since 2002 while cases in US residents has risen.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
AUGUST 16, 2023
Topics discussed include care workflow, app functionalities, problems and disadvantages, and benefits for HIV experts.
STAT
AUGUST 16, 2023
U.S. regulators on Wednesday approved the first treatment for an ultra-rare disease that causes people to grow bone where it otherwise shouldn’t be, extending an option to patients who have been advocating for access to the medicine. The treatment, an oral medication that will be marketed as Sohonos, faced some questions about the quality of its data, and was rejected earlier this year by European regulators.
Fierce Healthcare
AUGUST 16, 2023
Online messages have become a linchpin of many patients’ relationships with their doctors. | An influx of patient portal messages during recent years are taking a toll on clinicians. As a result, at least 22 systems across the country have added a price tag to the subset of missives demanding the most time and expertise.
European Pharmaceutical Review
AUGUST 16, 2023
Sandoz has announced positive results from the MYLIGHT Phase III study for its biosimilar aflibercept, for patients living with wet macular degeneration. The confirmatory efficacy and safety study ( NCT04864834 ) demonstrated therapeutic equivalence between the biosimilar aflibercept and the reference biologic, Eylea®. The study met its primary efficacy endpoint, showing therapeutic equivalence in mean change of best corrected visual acuity (BCVA) from baseline to week 8 between the biosimilar a
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
AUGUST 16, 2023
Figuring out the right medical diagnosis for patients can be a tricky process. The recent case of a woman who became sick with a life-threatening disease shortly after giving birth shows how many factors had to align to offer clinicians new insights into a rare complication that had never before been documented. A letter published Wednesday in the New England Journal of Medicine highlights the circumstances of the unusual case that occurred at University of Colorado Hospital.
Fierce Healthcare
AUGUST 16, 2023
National Quality Forum is joining the Joint Commission in a merger deal that the groups say will allow both to refine quality and outcome measures they develop for the industry. | The combination will help bolster Joint Commission’s standard development processes, expand the National Quality Forum's platform and refine both groups' quality measures, leaders said in the announcement.
STAT
AUGUST 16, 2023
For only the fifth time, the U.S. Food and Drug Administration recently threatened to fine a company or clinical trial investigator for failing to post study results on a federal government database. And transparency advocates say this is the latest proof that the agency needs to step up enforcement. In a July 19 letter , the FDA warned Light Sciences Oncology about its failure to post study results about a prostate treatment to the database, ClinicalTrials.gov.
Drug Store News
AUGUST 16, 2023
Taro is debuting FeverAll Children’s Liquid Oral Acetaminophen and bébé Bottoms Diaper Rash Crème Spray.
Fierce Healthcare
AUGUST 16, 2023
The collapse of insurtechs Bright Health and Friday Health Plans might mean that legacy health insurers in states where Bright and Friday operated will not receive over $1 billion worth of expected | Florida Blue, HCSC, Medica, Centene and Molina Healthcare might also suffer because of the financial troubles experienced by Bright Health and Friday Health Plans by not receiving risk-adjustment payments, an expert said.
STAT
AUGUST 16, 2023
Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today is butter pecan, a household favorite — and get started. Meanwhile, do keep us in mind if you hear anything interesting.
Pharmaceutical Technology
AUGUST 16, 2023
Bluebird bio eyes hattrick of gene therapy approvals, with a PDUFA date for sickle cell disease therapy lovo-cel set in December.
STAT
AUGUST 16, 2023
First Opinion , STAT’s platform for opinion and perspective essays, welcomes submissions about the biopharma industry, medical science and health care, and other topics related to the life sciences writ large.
Pharmaceutical Technology
AUGUST 16, 2023
Several companies are developing robotics to automate cell and gene therapy manufacturing, but some challenges persist.
Drug Store News
AUGUST 16, 2023
Michael Schwartz, CEO of Inverness, takes viewers into a step-by-step technique of its ear piercing process and discusses how the company’s partnership with Ulta Beauty came to life.
Fierce Healthcare
AUGUST 16, 2023
Insurers still have plenty of work to do when it comes to improving member satisfaction, according to a new survey. | Insurers still have plenty of work to do when it comes to improving member satisfaction, according to a new survey.
Drug Store News
AUGUST 16, 2023
The company announced that its products have recently launched into 5,000 new locations across several retailers, including Target, Albertsons, CVS, H-E-B, Sprouts and Winn-Dixie.
Fierce Healthcare
AUGUST 16, 2023
The Physicians Foundation has opened applications for a grant award and fellowship program aimed at helping drive awareness and best practices around the social determinants of health (SDOH). | The grant award and fellowship program are aimed at helping drive awareness and best practices around the social determinants of health. They are open to medical associations and doctors, respectively.
pharmaphorum
AUGUST 16, 2023
Gilead taps Tentarix for cancer, inflammation projects Phil.
Drug Store News
AUGUST 16, 2023
The acquisition will add approximately 400 Winn-Dixie and Harveys Supermarket locations across Alabama, Florida, Georgia, Louisiana and Mississippi.
Expert insights. Personalized for you.
247 
Let's personalize your content